Demcon Investment
Investor profile
Venture capital
Demcon Investment has backed 4 European tech companies across 4 funding rounds between 2022 and 2024, joining rounds totalling €55M. Most active in Healthtech and Agritech. Data as of Nov 2026.
Also recorded as: Demcon · Demcon Investment Fund
Deals
4
distinct rounds
Companies
4
backed
Active span
2022–2024
3 yrs
Total round €
€55M
sum of rounds joined
Deals by year
distinct rounds / yearDemcon Investment — deals by year — interactive chart.
Data table
| Demcon Investment — deals by year | |
|---|---|
| 2022 | 2 |
| 2024 | 2 |
Top sectors
by dealsDemcon Investment — top sectors — interactive chart.
Data table
| Demcon Investment — top sectors | |
|---|---|
| Healthtech | 4 |
| Agritech | 1 |
Stages
by dealsDemcon Investment — stages — interactive chart.
Data table
| Demcon Investment — stages | |
|---|---|
| Other | 2 |
| Series A | 1 |
| Series B | 1 |
Countries
by dealsDemcon Investment — countries — interactive chart.
Data table
| Demcon Investment — countries | |
|---|---|
| Netherlands | 4 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- ABN AMRO1
- Dutch Government1
- European Circular Bioeconomy Fund (ECBF)1
- Evonik Venture Capital GmbH1
- Graduate Entrepreneur Fund1
- i&i Biotech Fund1
- InnovationQuarter1
- Libertatis Ergo Holding BV (LEH)1
- Libertatis Ergo Holding of Leiden University1
- NLC Health Ventures1
- Novalis Biotech1
- Oost NL1
- Swanbridge Capital1
- Takeda Ventures1
- Van Herk Ventures1
- VisVires New Protein1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| In Ovo | Netherlands | 1 | €34M |
| Enzyre | Netherlands | 1 | €12M |
| Spatium Medical | Netherlands | 1 | €5.0M |
| Kaminari Medical | Netherlands | 1 | €3.8M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| In Ovo | Series B | €34M | 2022-03 |
| Enzyre | Series A | €12M | 2022-11 |
| Spatium Medical | Other | €5.0M | 2024-09 |
| Kaminari Medical | Other | €3.8M | 2024-10 |